Audio Journal of OncologyThorsten Kühn MD PhD; SABCS 2025: No Need for Axillary Node Dissection When Clinically Node-Positive Breast Cancers Convert to Node-Negative After Neoadjuvant Chemotherapy
Breast cancer staging: neoadjuvant chemotherapy benefits
19/02/20269:30
Audio Journal of OncologyMaría-Victoria Mateos; ASH 2025: Unprecedented Survival Benefits with BCMA/CD3 Bispecific Antibody Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma: Majestec-3 Study Findings
relapsed/refractory multiple myeloma bi-specific antibody: big benefits
13/02/20268:01
Audio Journal of OncologyErika Hamilton MD; 2025 SABCS: Small Molecule HER2 Inhibitor Tucatinib Improves Progression Free Survival in Patients with HER2-positive Metastatic Breast Cancer: in HER2CLIMB-05 Trial
Erika Hamilton MD; 2025 SABCS: Small Molecule HER2 Inhibitor Tucatinib Improves Progression Free Survival in Patients with HER2-positive Metastatic Breast Cancer: in HER2CLIMB-05 Trial An interview wi
10/02/20267:40
Audio Journal of OncologyWojciech Jurczak MD PhD; ASH 2025: Big Study Suggests Non-Covalent BTK Inhibitor Pirtobrutinib Could be New Standard-of-Care for Patients with Untreated Chronic Lymphocytic Leukemia
Wojciech Jurczak MD PhD; ASH 2025: Big Study Suggests Non-Covalent BTK Inhibitor Pirtobrutinib Could be New Standard-of-Care for Patients with Untreated Chronic Lymphocytic Leukemia An interview with:
05/02/202610:19
Audio Journal of OncologyGaorav Gupta MD PhD; SABCS 2025: Pre-Op Radiation Improved T-cell Infiltration in Hormone Receptor-positive, HER2-negative Invasive Breast Cancer; Could Boost Systemic Therapy Responses
Improved Responses to Anti-PD-1 immune therapy and chemotherapy could result from neoadjuvant radiation therapy for invasive luminal breast cancer
03/02/2026
Audio Journal of OncologyAmir Fathi MD; ASH 2025: Paradigm Study Finds Young, Fit Adults with Acute Myeloid Leukemia Do Better with Gentler Azacitidine/Venetoclax Initial Therapy
Gentler therapy for AML in young fit patients had better outcomes compared to standard induction chemotherapy
28/01/2026
Audio Journal of OncologyJennifer A. Woyach MD, ASH 2024: The Non-Covalent Bruton’s Tyrosine Kinase-Inhibitor Pirtobrutinib is As Effective, While Less Toxic, In Relapsed/Refractory Chronic Lymphocytic Leukemia
Non-Covalent BTK Inhibitor First in CLL: Less Toxic, As Effective as Covalent
24/01/2026
Audio Journal of OncologyAlexis Ann LeVee MD; 2025 SABCS: Pre-Operative Gut Microbiome Predicts Complete Response to Immune Checkpoint Inhibition in Patients with Early-stage HER2-positive Breast Cancer
Healthy eating could be a key to breast cancer treatment success: microbiome influence in immunotherapy outcomes identified,
22/01/2026
Audio Journal of OncologyAntonio Jimenez Jimenez MD MS; ASH 2025: Donor Choice No Longer a Barrier to Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies
The donor pool for allogeneic stem cell transplantation could be greatly increased, improving access to transplant for minorities who are currently excluded for transplantation according to findings of this big American study.
19/01/2026
